Minicircle‐DNA production by site specific recombination and protein–DNA interaction chromatography

Abstract

The results obtained in the present study demonstrate that the described technology facilitates the production of highly pure minicircle-DNA for direct application in gene therapy and vaccination. The process described is efficient, stable and suitable for further scale-up in industrial large-scale manufacturing.